Gerald Maginnis Purchases 6,000 Shares of inTEST (NYSE:INTT) Stock

Gerald Maginnis, Director of inTEST Co., purchased 6,000 shares of the company's stock at $7.44 per share, totaling $44,640. This acquisition increased his ownership by 7.69%, now holding 84,057 shares valued at $625,384.08. The transaction was disclosed in a legal SEC filing. inTEST's stock rose 1.2% to $7.54, with a market cap of $94.12 million. Analysts have a consensus "Moderate Buy" rating with a target price of $12.00. Institutional investors own 63.18% of the stock.

inTEST Co. (NYSE:INTT - Get Free Report) Director Gerald Maginnis bought 6,000 shares of the business's stock in a transaction on Wednesday, November 19th. The stock was bought at an average price of $7.44 per share, with a total value of $44,640.00. Following the transaction, the director owned 84,057 shares in the company, valued at approximately $625,384.08. This represents a 7.69% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

inTEST Stock Up 1.2%

Shares of NYSE INTT traded up $0.09 during mid-day trading on Thursday, reaching $7.54. The company had a trading volume of 5,210 shares, compared to its average volume of 39,358. inTEST Co. has a twelve month low of $5.24 and a twelve month high of $9.77. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.38 and a current ratio of 2.26. The stock has a market capitalization of $94.12 million, a PE ratio of 32.78 and a beta of 1.61. The stock's 50 day moving average is $8.08 and its 200-day moving average is $7.30.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on INTT shares. Zacks Research downgraded inTEST from a "strong-buy" rating to a "hold" rating in a research note on Monday, October 6th. Lake Street Capital restated a "buy" rating on shares of inTEST in a report on Thursday, November 6th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $12.00.

View Our Latest Report on inTEST

Institutional Investors Weigh In On inTEST

Large investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. grew its stake in inTEST by 187.0% in the 1st quarter. Russell Investments Group Ltd. now owns 124,959 shares of the company's stock valued at $873,000 after buying an additional 81,416 shares during the last quarter. AMH Equity Ltd increased its stake in shares of inTEST by 38.1% in the second quarter. AMH Equity Ltd now owns 163,000 shares of the company's stock worth $1,187,000 after purchasing an additional 45,010 shares during the period. Royce & Associates LP lifted its position in shares of inTEST by 2.4% during the 1st quarter. Royce & Associates LP now owns 1,467,649 shares of the company's stock worth $10,259,000 after purchasing an additional 34,550 shares during the last quarter. Bailard Inc. bought a new stake in inTEST during the 3rd quarter valued at approximately $251,000. Finally, Franklin Resources Inc. acquired a new stake in inTEST in the 3rd quarter valued at approximately $146,000. Institutional investors own 63.18% of the company's stock.

About inTEST

(Get Free Report)

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.

Five stocks we like better than inTEST
The Basics of Support and Resistance
NVIDIA Just Proved the AI Boom Is Bigger Than Anyone Thought
Stock Market Upgrades: What Are They?
Why Target Stock May Keep Falling Despite a 5% Dividend Yield
Should You Invest in Penny Stocks?
Is Tesla Setting Up for a Year-End Rebound—or a Collapse?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in inTEST Right Now?

Before you consider inTEST, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and inTEST wasn't on the list.

While inTEST currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here